Cargando…
A potential link between plasma short-chain fatty acids, TNF-α level and disease progression in non-alcoholic fatty liver disease: A retrospective study
The onset and progression of non-alcoholic fatty liver disease (NAFLD) remains unclear, but short-chain fatty acids (SCFAs) in circulation may participate in its pathogenesis by acting as inflammation inhibitors. The aim of this retrospective study was to investigate plasma concentrations of general...
Autores principales: | Xiong, Jing, Chen, Xia, Zhao, Zhijing, Liao, Ying, Zhou, Ting, Xiang, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353543/ https://www.ncbi.nlm.nih.gov/pubmed/35949337 http://dx.doi.org/10.3892/etm.2022.11536 |
Ejemplares similares
-
Short-chain fatty acids in diseases
por: Zhang, Dan, et al.
Publicado: (2023) -
Circulating Short-Chain Fatty Acids and Non-Alcoholic Fatty Liver Disease Severity in Patients with Type 2 Diabetes Mellitus
por: Tsai, Hui-Ju, et al.
Publicado: (2023) -
Roles of short-chain fatty acids in kidney diseases
por: Li, Ling-Zhi, et al.
Publicado: (2019) -
Short-chain fatty acids in the context of Parkinson’s disease
por: Metzdorf, Judith, et al.
Publicado: (2021) -
Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease
por: Chen, Szu-Ju, et al.
Publicado: (2022)